![Bo Jesper Hansen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Bo Jesper Hansen
Président chez
Innoventa Medica ApS
Profil
Bo Jesper Hansen is the founder of Scandinavian Medical Research.
He currently holds multiple positions, including Chairman at Innoventa Medica ApS, Director at Reapplix A, Director at MipSalus ApS, Director at CMC Sweden AB, Venture Partner at Wellington Partners GmbH, and Member-Supervisory Board at Amylon Therapeutics BV.
In the past, Dr. Hansen held various roles, such as President & Chief Executive Officer at Swedish Orphan International Holding AB, President, Chief Executive Officer & Director at Swedish Orphan Biovitrum International AB, Chairman at 2941881 Canada, Inc. and Karo Healthcare AB, Executive Chairman at Topotarget A, Chairman at Biovitrum AB, Chairman at Karolinska Development AB. (Private Equity), Chairman at Ablynx NV, Chairman at Strategic Partners A, Chairman at Swedish Orphan Biovitrum AB, Chairman at Swedish Orphan Biovitrum AB, Chairman at Karolinska Development AB, Independent Non-Executive Director at Hyperion Therapeutics, Inc., Independent Director at Rebus Holdings, Inc., Director at Gambro AB, Director at Incentive AB, Director at Valerio Therapeutics SA, Independent Non-Executive Director at Newron Pharmaceuticals SpA, Director at ACE BioSciences ApS, Director at Zymenex A, Director-Supervisory Board at Novagali Pharma SA, and Non-Executive Director at Azanta A. Dr. Hansen's education includes a doctorate degree from the University of Copenhagen.
Postes actifs de Bo Jesper Hansen
| Sociétés | Poste | Début |
|---|---|---|
MipSalus ApS
 MipSalus ApS Miscellaneous Commercial ServicesCommercial Services Engages in research and experimental development on natural sciences and engineering | Directeur/Membre du Conseil | 15/03/2011 |
Wellington Partners GmbH
 Wellington Partners GmbH Investment ManagersFinance Wellington Partners invests in companies located in Germany, Europe and beyond. The firm focuses on life sciences companies. It provides financing for early and growth stage capital requirements with an investments size of EUR 2 - 20 million. It also acts as a lead and co-lead investor. | Private Equity Investor | - |
Innoventa Medica ApS | Président | - |
Amylon Therapeutics BV
 Amylon Therapeutics BV Pharmaceuticals: MajorHealth Technology Develops therapies for central nervous system | Directeur/Membre du Conseil | - |
CMC Sweden AB
 CMC Sweden AB Industrial MachineryProducer Manufacturing Manufactures lifting and handling equipment | Directeur/Membre du Conseil | - |
Reapplix A/S
 Reapplix A/S Medical SpecialtiesHealth Technology Manufactures wound healing patches made from patient's blood that for the biological treatment and management of diabetic foot ulcers | Directeur/Membre du Conseil | - |
Anciens postes connus de Bo Jesper Hansen
| Sociétés | Poste | Fin |
|---|---|---|
| SWEDISH ORPHAN BIOVITRUM AB | Président | 05/01/2024 |
| STRATEGIC PARTNERS A/S | Président | 17/05/2023 |
Azanta A/S
 Azanta A/S Pharmaceuticals: MajorHealth Technology Provides pharmaceutical drugs within oncology, women's healthcare, and addiction medicine | Directeur/Membre du Conseil | 24/03/2020 |
| ░░░░░░ ░░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Bo Jesper Hansen
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
71
Relations au 1er degré
34
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 34 |
|---|---|
CMC Contrast AB
 CMC Contrast AB Pharmaceuticals: MajorHealth Technology develops magnetic resonance contrast agents for patients suffering with tumors | Health Technology |
Hyperion Therapeutics, Inc.
 Hyperion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products | Health Technology |
Rebus Holdings, Inc.
 Rebus Holdings, Inc. BiotechnologyHealth Technology Engages in research and development of novel targeted precision therapeutics | Health Technology |
2941881 Canada, Inc.
 2941881 Canada, Inc. Medical SpecialtiesHealth Technology Manufactures and supplies medical equipment for the diagnosis and treatment of disorders in urology, gynecology, colorectal and gastrointestinal | Health Technology |
Gambro AB
 Gambro AB Medical SpecialtiesHealth Technology Develops and manufactures dialysis equipment and blood purification products | Health Technology |
Karo Healthcare AB
 Karo Healthcare AB Household/Personal CareConsumer Non-Durables Manufactures skincare products, cosmetics, supplements and digestive pharmaceuticals | Consumer Non-Durables |
Incentive AB
 Incentive AB Financial ConglomeratesFinance Makes miscellaneous investments | Finance |
Topotarget A/S
 Topotarget A/S Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceuticals | Health Technology |
Wellington Partners GmbH
Wellington Partners GmbH Investment ManagersFinance Wellington Partners invests in companies located in Germany, Europe and beyond. The firm focuses on life sciences companies. It provides financing for early and growth stage capital requirements with an investments size of EUR 2 - 20 million. It also acts as a lead and co-lead investor. | Finance |
Biovitrum AB
 Biovitrum AB Miscellaneous Commercial ServicesCommercial Services Develops pharmaceuticals and conducts medical research services | Commercial Services |
Valerio Therapeutics SA
 Valerio Therapeutics SA Pharmaceuticals: MajorHealth Technology Develops drugs for the treatment of cancer | Health Technology |
Swedish Orphan International Holding AB
 Swedish Orphan International Holding AB Pharmaceuticals: MajorHealth Technology Develops, manufactures and sells pharmaceutical products and drugs | Health Technology |
Karolinska Development AB (Private Equity)
 Karolinska Development AB (Private Equity) Investment ManagersFinance Karolinska Development seeks investment in companies located in the Nordic region, primarily in Swedish. The firm targets companies operating in the fields of health technology, health services, medical devices, technology services, life science. It provides financing for early stage capital requirements. It takes a seat on the board of directors. | Finance |
Newron Pharmaceuticals SpA
 Newron Pharmaceuticals SpA Pharmaceuticals: MajorHealth Technology Develops and sells novel therapies central & peripheral nervous system | Health Technology |
Ablynx NV
 Ablynx NV BiotechnologyHealth Technology Develops and produces antibodies | Health Technology |
ACE BioSciences ApS
 ACE BioSciences ApS Pharmaceuticals: MajorHealth Technology Discovers and develops novel vaccines for the prevention and treatment of bacterial infections | Health Technology |
Zymenex A/S
 Zymenex A/S BiotechnologyHealth Technology Engages in the research and development of therapeutics for life threatening diseases | Health Technology |
Novagali Pharma SA
 Novagali Pharma SA Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs for eye treatment | Health Technology |
University of Copenhagen
 University of Copenhagen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Yamanouchi Nordic | |
Scandinavian Medical Research | |
Synthélabo Scandinavia A/S | |
Azanta A/S
Azanta A/S Pharmaceuticals: MajorHealth Technology Provides pharmaceutical drugs within oncology, women's healthcare, and addiction medicine | Health Technology |
Swedish Orphan Biovitrum International AB
 Swedish Orphan Biovitrum International AB Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes pharmaceutical products and drugs | Health Technology |
Pfizer ApS
 Pfizer ApS Medical DistributorsDistribution Services Wholesales pharmaceutical goods and medical supplies | Distribution Services |
Strategic Partners A/S
 Strategic Partners A/S Pharmaceuticals: MajorHealth Technology Provides therapeutic treatment of of diseases caused by defects in the function and metabolism of proteins | Health Technology |
Reapplix A/S
Reapplix A/S Medical SpecialtiesHealth Technology Manufactures wound healing patches made from patient's blood that for the biological treatment and management of diabetic foot ulcers | Health Technology |
Swedish Orphan Biovitrum AB
 Swedish Orphan Biovitrum AB Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceuticals and orphan drugs in the areas of hematology, immunology and specialty care | Health Technology |
MipSalus ApS
MipSalus ApS Miscellaneous Commercial ServicesCommercial Services Engages in research and experimental development on natural sciences and engineering | Commercial Services |
Karolinska Development AB
 Karolinska Development AB Financial ConglomeratesFinance Operates as a life sciences investment company | Finance |
Ascelia Pharma AB
 Ascelia Pharma AB Pharmaceuticals: MajorHealth Technology Operates as oncology-dedicated drug development company, which develops novel drugs to improve life expectancy | Health Technology |
Innoventa Medica ApS | |
Amylon Therapeutics BV
Amylon Therapeutics BV Pharmaceuticals: MajorHealth Technology Develops therapies for central nervous system | Health Technology |
CMC Sweden AB
CMC Sweden AB Industrial MachineryProducer Manufacturing Manufactures lifting and handling equipment | Producer Manufacturing |
